CAH vs CODX · P/E 35, rev $222.58B vs rev $3.9M
Cardinal Health Inc (CAH) versus Co-Diagnostics, Inc. Common Stock (CODX) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. CODX currently screens at market cap $31.4M.
Not investment advice. Open the CAH and CODX stock pages for the full models.
Not investment advice.